港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

首鋼朗澤

成交量：- -

成交額：- -

市值：- -

市盈率：- -

高：- -

開：- -

低：- -

收：- -

52周最高：- -

52周最低：- -

股本：3.60億

香港流通股本：3.60億

量比：- -

換手率：- -

股息：- -

股息率：- -

淨資產收益率：-23.25%

總資產收益率：-5.36%

市淨率：0.00

市盈率(LYR):- -

市銷率: 0.00

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

「人造肉第一股」敗走中國市場，國產新質蛋白能否突圍？

食品创新研究所

首鋼朗澤技術成果正式納入國家科技傳播中心科技成就展數字展品庫

CCUS賽道潛力釋放，首鋼朗澤推進合成生物技術產業化

中国财富网

IPO一周要聞丨香港上市井噴北芯生命上會

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02553"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02553","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02553\",,,,,undefined,":{"symbol":"02553","market":"HK","secType":"STK","nameCN":"首鋼朗澤","latestPrice":0,"timestamp":1770796800000,"preClose":0,"halted":9,"volume":0,"delay":0,"floatShares":360000000,"shares":360000000,"eps":0,"marketStatus":"已收盤","change":0,"latestTime":"02-11 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1770859800000},"marketStatusCode":5,"adr":0,"listingDate":1752508800000,"exchange":"SEHK","adjPreClose":0,"openAndCloseTimeList":[[1770773400000,1770782400000],[1770786000000,1770796800000]],"volumeRatio":0,"greyMarketDetail":{"greyDate":"2025-07-14","greyDateTimestamp":1752422400000,"greyOpeningTime":1752480900000,"greyClosingTime":1752489000000,"showGreyQuote":false,"openProspectusDate":"2025-07-07","listingDate":"2025-07-15"},"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02553\",,,,,undefined,":{"symbol":"02553","floatShares":360000000,"roa":"-5.36%","roe":"-23.25%","lyrEps":0,"shares":360000000,"dividePrice":0,"high":0,"amplitude":0,"preClose":0,"low":0,"week52Low":0,"pbRate":"0.00","psRate":"0.00","week52High":0,"institutionHeld":0,"latestPrice":0,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":0,"open":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02553\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02553\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02553\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02553\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02553","date":"2025-07-18","current":-42.237026,"percent":0.5,"low":-42.242804,"twenty":-42.238182,"median":-42.237026,"eighty":-42.189414,"high":-42.163874,"avg":-42.215306,"sd":0.030742,"marketCap":6344867062},"quantilePoints":[{"date":"2025-07-18","current":-42.237026,"twenty":-42.238182,"median":-42.237026,"eighty":-42.189414,"marketCap":6344867062}],"updateTime":1770771696164},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02553\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2593494616","title":"「人造肉第一股」敗走中國市場，國產新質蛋白能否突圍？","url":"https://stock-news.laohu8.com/highlight/detail?id=2593494616","media":"食品创新研究所","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593494616?lang=zh_tw&edition=fundamental","pubTime":"2025-12-23 13:24","pubTimestamp":1766467482,"startTime":"0","endTime":"0","summary":"2019年5月，Beyond Meat在纽约证券交易所上市，成为全球“人造肉第一股”。国际上另一家知名“人造肉”公司Impossible Foods在2020年初回应《牧食记》问询时亦表示，虽然当时没有具体的计划要在中国大陆上市，但这肯定是公司想尽快实现的一个目标。综合各个渠道的反馈来看，“人造肉”市场遇冷的主要原因包括产品口感与真肉存在差距、价格缺乏竞争力等。截至12月18日收盘，Beyond Meat的股价已跌至1.04美元，公司总市值仅为4.72亿美元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223132842a6c47321&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223132842a6c47321&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02553"],"gpt_icon":0},{"id":"2592994760","title":"首鋼朗澤技術成果正式納入國家科技傳播中心科技成就展數字展品庫","url":"https://stock-news.laohu8.com/highlight/detail?id=2592994760","media":"中钢网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592994760?lang=zh_tw&edition=fundamental","pubTime":"2025-12-17 11:02","pubTimestamp":1765940540,"startTime":"0","endTime":"0","summary":"北京首钢朗泽科技股份有限公司获中国环境科学学会推荐，在会上正式发布“含碳工业尾气生物发酵制乙醇及微生物蛋白技术”。该项技术作为重要成果，正式纳入国家科技传播中心科技成就展数字展品库，标志着其创新贡献获得国家级平台的高度认可与永久珍藏。金涌院士表示，首钢朗泽技术不仅是我国落实“双碳”战略、破解工业绿色转型瓶颈的关键创新，更是合成生物学与CCUS技术融合领域的标志性突破。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217110722a6ac00f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251217110722a6ac00f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02553"],"gpt_icon":0},{"id":"2557635721","title":"CCUS賽道潛力釋放，首鋼朗澤推進合成生物技術產業化","url":"https://stock-news.laohu8.com/highlight/detail?id=2557635721","media":"中国财富网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557635721?lang=zh_tw&edition=fundamental","pubTime":"2025-08-05 13:54","pubTimestamp":1754373250,"startTime":"0","endTime":"0","summary":"随着全球减碳政策的密集出台，CCUS行业迎来爆发式增长机遇，而首钢朗泽凭借合成生物技术的创新应用，在这一赛道上展现出强劲的引领力。合成生物技术落地生根，首钢朗泽打造行业标杆在CCUS行业加速扩张的浪潮中，首钢朗泽凭借合成生物技术的深度应用，构建起独特的竞争优势。作为CCUS行业的创新先锋，首钢朗泽以合成生物技术的产业化实践，为全球减碳事业提供了可复制的解决方案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805135846a475e33d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805135846a475e33d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02553"],"gpt_icon":0},{"id":"2552448888","title":"IPO一周要聞丨香港上市井噴 北芯生命上會","url":"https://stock-news.laohu8.com/highlight/detail?id=2552448888","media":"投资者网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2552448888?lang=zh_tw&edition=fundamental","pubTime":"2025-07-20 08:01","pubTimestamp":1752969691,"startTime":"0","endTime":"0","summary":"上交所上市审核委员会定于7月18日召开2025年第23次上市审核委员会审议会议。值得一提的是，继禾元生物过会后，北芯生命是本月第二家选取第五套标准的科创板IPO过会企业。目前，以该标准排队的科创板IPO企业共5家：除北芯生命外，恒润达生尚未上会；禾元生物、思哲睿、必贝特已提交注册。发行人通过上市委会议后，交易所将相关资料报送证监会，等待证监会作出同意或者不予注册的决定，只有获得证","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/07/20080151828246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0077","LU0708995153.HKD","LU0029874905.USD","BK0231","BK0201","688343","BK1137","688008","LU0229945570.USD","06610","BK0214","BK4080","BK0155","BK4231","01908","399300","LU0543330566.HKD","300568","LU0128522744.USD","002709","LU0320764243.SGD","BK0229","301536","159982","09887","ADC","BK1240","LU2039709279.SGD","BK0028","02553"],"gpt_icon":1}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":14,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/02553\",params:#limit:6,delay:false,,,undefined,":[]}}